These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1979273)

  • 1. Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats.
    Goudie AJ; Leathley MJ
    Eur J Pharmacol; 1990 Aug; 185(2-3):179-86. PubMed ID: 1979273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Oakley NR; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1989 Dec; 34(4):769-78. PubMed ID: 2576143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of anxiolytic action of ondansetron in rats during withdrawal from chronic chlordiazepoxide.
    Rezazadeh SM; Prather PL; Emmett-Oglesby MW; Lal H
    Ann N Y Acad Sci; 1992 Jun; 654():472-3. PubMed ID: 1352955
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of the 5-HT3 antagonist ondansetron on benzodiazepine-induced operant behavioural dependence in rats.
    Goudie AJ; Leathley MJ
    Psychopharmacology (Berl); 1992; 109(4):461-5. PubMed ID: 1365863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the dependence potential of the selective 5-H1A agonist ipsapirone in rats and of its effects on benzodiazepine withdrawal.
    Goudie AJ; Leathley MJ
    Psychopharmacology (Berl); 1991; 103(4):529-37. PubMed ID: 1676531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The anxiolytic effect of ondansetron and its capacity to eliminate the benzodiazepine abstinence syndrome in rats].
    Garibova TL; Voronina TA; Kraĭneva VA; Val'dman EA
    Eksp Klin Farmakol; 1999; 62(6):16-9. PubMed ID: 10650519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
    Prather PL; Rezazadeh SM; Lane JD; Rowan GA; Hooper ML; Lytle DA; Emmett-Oglesby MW; Lal H
    J Pharmacol Exp Ther; 1993 Feb; 264(2):622-30. PubMed ID: 8094750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal.
    Higgins GA; Nguyen P; Joharchi N; Sellers EM
    Psychopharmacology (Berl); 1991; 105(3):322-8. PubMed ID: 1839177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the 5-HT3 antagonist ICS 205-930 on benzodiazepine withdrawal signs in rats.
    Leathley MJ; Goudie AJ
    Behav Pharmacol; 1992 Feb; 3(1):51-56. PubMed ID: 11224101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist.
    Jones BJ; Costall B; Domeney AM; Kelly ME; Naylor RJ; Oakley NR; Tyers MB
    Br J Pharmacol; 1988 Apr; 93(4):985-93. PubMed ID: 2898961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.
    Butler A; Hill JM; Ireland SJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1988 Jun; 94(2):397-412. PubMed ID: 2969267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 5-hydroxytryptamine on external carotid nerve activity and its blockade by GR38032F in anesthetized rats.
    Yoshioka M; Ikeda T; Abe M; Togashi H; Saito H
    Res Commun Chem Pathol Pharmacol; 1991 Oct; 74(1):39-45. PubMed ID: 1839326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GR38032F, a serotonin 5-HT3 antagonist, fails to alter cocaine self-administration in rats.
    Peltier R; Schenk S
    Pharmacol Biochem Behav; 1991 May; 39(1):133-6. PubMed ID: 1833779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a novel 5-hydroxytryptamine3-antagonist, GR38032F, on the 5-hydroxytryptamine-induced increase in carotid sinus nerve activity in rats.
    Yoshioka M
    J Pharmacol Exp Ther; 1989 Aug; 250(2):637-41. PubMed ID: 2527299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose ranging phase I study of the serotonin antagonist GR38032F for prevention of cisplatin-induced nausea and vomiting.
    Grunberg SM; Stevenson LL; Russell CA; McDermed JE
    J Clin Oncol; 1989 Aug; 7(8):1137-41. PubMed ID: 2526864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin-induced conditioned taste aversion: attenuation by dexamethasone but not zacopride or GR38032F.
    Mele PC; McDonough JR; McLean DB; O'Halloran KP
    Eur J Pharmacol; 1992 Aug; 218(2-3):229-36. PubMed ID: 1330594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ondansetron administration on opioid withdrawal syndrome observed in rats.
    Pinelli A; Trivulzio S; Tomasoni L
    Eur J Pharmacol; 1997 Dec; 340(2-3):111-9. PubMed ID: 9537805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine.
    King GR; Xiong Z; Ellinwood EH
    Psychopharmacology (Berl); 1998 Feb; 135(3):263-9. PubMed ID: 9498729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.